STAAR Surgical to Present at the Canaccord Genuity 6th Annual Medical Device Conference

MONROVIA, Calif., Dec. 1, 2011 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced that it will participate in the Canaccord Genuity 6th Annual Cardiovascular, Aesthetics & Metabolic Disorder Medical Device Conference at the St. Regis Hotel in San Francisco. STAAR's presentation will be on Tuesday, December 6, 2011 at 3:40 p.m. Pacific Time.

Barry G. Caldwell, President and CEO, will review the company's business strategy to expand revenue growth during 2012 and the impact of recent new product approvals to that growth.  Deborah Andrews, CFO, and Don Todd, President of Asia Pacific, will also be attending the conference. STAAR will offer a live video webcast of its presentation on the Company's website, www.staar.com, under Investor Information. An archived replay of the presentation will be available for 30 days, also at www.staar.com.

About STAAR Surgical

STAAR, which has been dedicated solely to ophthalmic surgery for over 25 years, designs, develops, manufactures and markets implantable lenses for the eye.  All of these lenses are foldable, which permits the surgeon to insert them through a small incision.  STAAR's lens used in refractive surgery as an alternative to LASIK is called an Implantable Collamer® Lens or "ICL."  A lens used to replace the natural lens after cataract surgery is called an intraocular lens or "IOL."  Over 250,000 Visian ICLs have been implanted to date; to learn more about the ICL go to: www.visianinfo.com.  STAAR has approximately 300 full time employees and markets lenses in approximately 50 countries.  Headquartered in Monrovia, CA, it manufactures in the following locations: Nidau, Switzerland; Ichikawa City, Japan; Aliso Viejo, CA; and Monrovia, CA.  For more information, please visit the Company's website at www.staar.com or call 626-303-7902. 

Collamer® is the registered trademark for STAAR's proprietary biocompatible collagen copolymer lens material. 

SOURCE STAAR Surgical Company

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED